Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis

BACKGROUND: We synthesize the efficacy and toxicity of poly(ADP-ribose) polymerase inhibitors (PARPis) in patients with newly diagnosed advanced ovarian cancer. PATIENTS AND METHODS: We manually extracted individual patient data (IPD) for progression-free survival (PFS) from published survival curve...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulia, S., Kannan, S., Ghosh, J., Rath, S., Maheshwari, A., Gupta, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588903/
https://www.ncbi.nlm.nih.gov/pubmed/36007449
http://dx.doi.org/10.1016/j.esmoop.2022.100558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588903/
https://www.ncbi.nlm.nih.gov/pubmed/36007449
http://dx.doi.org/10.1016/j.esmoop.2022.100558

Ejemplares similares